Subjective smell‐ and taste loss in diabetes—A questionnaire‐based study on 47 011 individuals with diabetes and matched controls
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Alexander Wieck Fjaeldstad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Regional Hospital Gødstrup, Flavour Clinic, University Clinic for Flavour, Balance and Sleep, Herning, Denmark. Hauptthemen laut MEDLINE: Olfaction Disorders, Diabetes Mellitus, Type 2, Taste Disorders, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Velux Fonden, Steno Diabetes Center Aarhus (Novo Nordisk Foundation), Novo Nordisk Fonden.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Taste and smell disorders are more common in individuals with diabetes, particularly among those with low insulin sensitivity or central obesity. These disorders may affect glycaemic control by altering dietary habits. This study aimed to investigate self‐reported taste and smell dysfunction in individuals with diabetes and explore associations with clinical and behavioural factors.
Methods
We examined self‐reported taste and smell disorders in 47,011 individuals with or without diabetes using data from the Health in Central Denmark (HICD) cohort. In total, eight questions on subjective smell and taste function were included in the questionnaire.
Results
Participants with type 2 diabetes reported significantly more qualitative and quantitative chemosensory complaints than matched controls. In contrast, no significant differences were found between individuals with Type 1 Diabetes and controls. Smoking was consistently associated with increased complaints across all groups, while HbA1c levels showed no correlation with taste or smell disorders. Obesity, particularly in women with diabetes, was linked to higher symptom reporting Conclusions Individuals with type 2 diabetes report more chemosensory complaints than controls. Smoking and obesity, but not HbA1c, were associated with a higher prevalence of symptoms. As subjective rating tends to underestimate true prevalence, future research should include objective testing to clarify how chemosensory disorders affect dietary behaviour and diabetes management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Regional Hospital Gødstrup, Flavour Clinic, University Clinic for Flavour, Balance and Sleep, Herning, Denmark.
- Flavour Institute, Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark.
- Centre for Eudaimonia and Human Flourishing, Linacre College, University of Oxford, Oxford, UK.
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus N, Denmark.
- Department of Public Health, Aarhus University, Aarhus C, Denmark.
ORCID-Profile: Alexander Wieck Fjaeldstad
Förderung
- Velux Fonden
- Steno Diabetes Center Aarhus (Novo Nordisk Foundation)
- Novo Nordisk Fonden
Zitieren
APA
Fjaeldstad, A. W., Norman, K., & Bjerg, L. (2025). Subjective smell‐ and taste loss in diabetes—A questionnaire‐based study on 47 011 individuals with diabetes and matched controls. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70099
Vancouver
Fjaeldstad AW, Norman K, Bjerg L. Subjective smell‐ and taste loss in diabetes—A questionnaire‐based study on 47 011 individuals with diabetes and matched controls. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.70099
BibTeX
@article{Fjaeldstad2025,
author = {Fjaeldstad, Alexander Wieck and Norman, Kasper and Bjerg, Lasse},
title = {Subjective smell‐ and taste loss in diabetes—A questionnaire‐based study on 47 011 individuals with diabetes and matched controls},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.70099}
}
EUVIMED